Metabolic syndrome and endothelial dysfunction
- PMID: 15748531
- DOI: 10.1007/s11906-005-0080-6
Metabolic syndrome and endothelial dysfunction
Abstract
The incidence of metabolic syndrome is rapidly increasing in the United States. Metabolic syndrome is associated with increased cardiovascular morbidity and mortality, and endothelial dysfunction is an early pathogenetic event in the metabolic syndrome. Endothelial dysfunction of either the coronary, the peripheral, or the cerebral vasculature is a predictor of vascular events and appears to be a marker of uncontrolled atherosclerotic risk that adds to the burden of the genetic predisposition to cardiovascular disease. Clinically and experimentally, endothelial dysfunction can be restored by several agents, including blockers/inhibitors of the renin-angiotensin-aldosterone system, as well as statins. Nevertheless, it would be premature, and most likely inappropriate, to use improvement of endothelial function as a surrogate end point to predict reduction in cardiovascular morbidity and mortality. However, a clear understanding of the mechanisms of endothelial dysfunction in the metabolic syndrome may allow the development of preventive and early therapeutic measures targeting cardiovascular disease.
Similar articles
-
Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers.J Hypertens. 2010 Jan;28(1):2-8. doi: 10.1097/HJH.0b013e328332bcf0. J Hypertens. 2010. PMID: 19797978 Review.
-
Insulin resistance and the endothelium.Am J Med. 2004 Jul 15;117(2):109-17. doi: 10.1016/j.amjmed.2004.02.042. Am J Med. 2004. PMID: 15234647 Review.
-
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.Vasc Health Risk Manag. 2007;3(1):1-9. Vasc Health Risk Manag. 2007. PMID: 17583170 Free PMC article. Review.
-
Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?J Hypertens Suppl. 2006 Apr;24(2):S31-5. doi: 10.1097/01.hjh.0000220101.57896.cd. J Hypertens Suppl. 2006. PMID: 16601559 Review.
-
Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.J Hum Hypertens. 2004 Sep;18(9):599-606. doi: 10.1038/sj.jhh.1001714. J Hum Hypertens. 2004. PMID: 15190263 Review.
Cited by
-
The impact of different forms of exercise on circulating endothelial progenitor cells in cardiovascular and metabolic disease.Eur J Appl Physiol. 2022 Apr;122(4):815-860. doi: 10.1007/s00421-021-04876-1. Epub 2022 Jan 12. Eur J Appl Physiol. 2022. PMID: 35022875 Free PMC article. Review.
-
The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis.Sports Med. 2015 May;45(5):679-92. doi: 10.1007/s40279-015-0321-z. Sports Med. 2015. PMID: 25771785 Review.
-
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa).PLoS One. 2009;4(5):e5557. doi: 10.1371/journal.pone.0005557. Epub 2009 May 18. PLoS One. 2009. PMID: 19440378 Free PMC article.
-
Obesity, weight loss, and vascular function.Endocrine. 2006 Feb;29(1):21-5. doi: 10.1385/endo:29:1:21. Endocrine. 2006. PMID: 16622289 Review.
-
MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases.Biochim Biophys Acta. 2016 Dec;1861(12 Pt B):2094-2103. doi: 10.1016/j.bbalip.2016.01.013. Epub 2016 Jan 26. Biochim Biophys Acta. 2016. PMID: 26825686 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical